This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Impacting 99.9% Of The Hospital Budget

Earlier this year Getinge Canada Limited provided a grant to re-validate the data published in 2009.

The initial results look to be slightly better than reported in 2009.

  • Productivity improved by 45%
  • Total savings were just over $400K

"I am very pleased that the data originally peer reviewed and published in 2009, has been revalidated.  Hospitals now have a clear option, to invest in innovative reprocessing technology and realize high quality outcomes and significant savings to their hospital budget," stated Doug Friesen, President Getinge Canada Limited.

*CIHI

About Getinge Canada Limited

Getinge Canada Limited is a member of Getinge AB, a publicly-listed, Swedish-based group of companies. Worldwide, GETINGE ranks among the leading providers of disinfectors and sterilizers within the healthcare and life sciences segments. Since its foundation in 1904, Getinge Infection Control has stood for innovation and technological progress in the field of disinfection and sterilization. Together with the other two business areas, Extended Care (ARJOHUNTLEIGH) and Medical Systems (MAQUET), the entire Getinge Group focuses on state-of-the-art medical technology.

GETINGE GROUP:  www.getingegroup.com  Getinge Infection Control:  www.getinge.com

SOURCE Getinge Canada Limited

Image with caption: " Doug Friesen, President of Getinge Canada Limited (CNW Group/Getinge Canada Limited)". Image available at: http://photos.newswire.ca/images/download/20121130_C5025_PHOTO_EN_21387.jpg

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs